Arcturus Therapeutics Holdings Inc
ARCT
Company Profile
Business description
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.
Contact
10628 Science Center Drive
Suite 250
San DiegoCA92121
USAT: +1 858 900-2660
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
180
Stocks News & Analysis
stocks
Unconventional wisdom: A controversial income pick
Rigid definitions of income and growth shares may be holding investors back.
stocks
How to avoid dividend disaster
Thinking about common reasons a company might stop paying a dividend can help income investors avoid disappointment.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,780.30 | 4.80 | -0.05% |
| CAC 40 | 7,973.03 | 34.59 | -0.43% |
| DAX 40 | 21,787.00 | 115.42 | -0.53% |
| Dow JONES (US) | 44,303.40 | 444.23 | -0.99% |
| FTSE 100 | 8,700.53 | 26.75 | -0.31% |
| HKSE | 21,133.54 | 241.92 | 1.16% |
| NASDAQ | 19,523.40 | 268.59 | -1.36% |
| Nikkei 225 | 38,787.02 | 279.51 | -0.72% |
| NZX 50 Index | 12,902.19 | 57.60 | 0.45% |
| S&P 500 | 6,025.99 | 57.58 | -0.95% |
| S&P/ASX 200 | 8,511.40 | 9.30 | -0.11% |
| SSE Composite Index | 3,303.67 | 33.01 | 1.01% |